The need to pay more attention to modern wound treatments and improve the current methods has become increasingly obvious in the modern world.

Changes in lifestyle and population growth have increased the cases of chronic wounds, contusions, traumas, and burnings that need to be treated. For example, almost one-sixth of diabetics worldwide develop chronically infected diabetic ulcers, with a mortality rate comparable to cancers.

AKTISCHICHT has innovated modern technology and know-how with which 2 phenomenal new products in chronic wound healing are being manufactured. This technology and know-how have been being developed since 2009 in Europe and after years of research and passing the in-vitro, in-vivo, pre-clinical, and clinical stages according to European standards, AKTISCHICHT officially started manufacturing in a state-of-the-art production facility in the year 2020 and continues its R&D to develop new solutions for chronic wounds.